Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Current Topics in Behavioral Neurosciences|November 7, 2024
Ethical Aspects of Psychedelic-Assisted Treatments: An OverviewChristopher Poppe, Dimitris Repantis
Brain and Behavior|June 17, 2026
Expectations and Motivations for Participation in Clinical Trials Utilizing Psychedelics for Treatment-Resistant Depression: A Qualitative StudyChristopher Poppe, Liisa Lyck, Laura Bechtold, et al.
Psychological Medicine|September 29, 2025
Ethical issues with psychedelic-assisted treatments in psychiatry: A systematic scoping reviewChiara Caporuscio, Christopher Poppe, Astrid Gieselmann, et al.
Psychopharmacology|June 10, 2026
Attitudes and perceptions of psychedelic therapy among clinical trial participants with alcohol use disorder: a mixed-method studyJulian Kirsch, Christopher Poppe, Anne Beck, et al.
Pharmacological Research|March 3, 2010
Acetylcholinesterase inhibitors and memantine for neuroenhancement in healthy individuals: a systematic reviewDimitris Repantis, Oona Laisney, Isabella Heuser
Pharmacological Research|April 27, 2010
Modafinil and methylphenidate for neuroenhancement in healthy individuals: A systematic reviewDimitris Repantis, Peter Schlattmann, Oona Laisney, et al.
Human Brain Mapping|June 7, 2022
Cognitive enhancement: Effects of methylphenidate, modafinil, and caffeine on latent memory and resting state functional connectivity in healthy adultsMaxi Becker, Dimitris Repantis, Martin Dresler, et al.
Frontiers in Psychiatry|August 19, 2021
Moral Psychopharmacology Needs Moral Inquiry: The Case of PsychedelicsNicolas Langlitz, Erika Dyck, Milan Scheidegger, et al.
Psychopharmacology|November 17, 2020
Cognitive enhancement effects of stimulants: a randomized controlled trial testing methylphenidate, modafinil, and caffeineDimitris Repantis, Leonore Bovy, Kathrin Ohla, et al.
Nursing Ethics|February 5, 2020
Hopelessness in palliative care for people with motor neurone disease: Conceptual considerationsChristopher Poppe
Pageof 4